The prevalence and unique clinical features of CPFE among patients with connective tissue disease–associated interstitial lung disease: a retrospective, real-world study
Therapeutic Advances in Respiratory Disease · 2026-07 · 20
DOI: 10.1177/17534666261471313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 27.07.2026. Verfasst von Shuwan Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hos…. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Connective Tissue Diseases, Pulmonary Emphysema, Pulmonary Fibrosis. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key R & D Program of Hunan Province, the Natural Science Foundation of Hunan Province, China, The National Key Clinical Specialist Construction Program of China.
Abstract (Originalsprache)
Background
Combined pulmonary fibrosis and emphysema (CPFE) is a distinct yet clinically underrecognised syndrome. Interstitial pneumonia is a common pulmonary manifestation of connective tissue diseases (CTDs), and some CTD-interstitial lung disease (CTD-ILD) patients have concurrent emphysema that is frequently overlooked clinically.
Objectives
This study explored the clinical characteristics and factors associated with emphysema in CTD-ILD patients to guide clinical management.
Design
This single-centre retrospective study included patients with CTD-related lung diseases from the ILD database of Xiangya Hospital. Patients were screened with standardised respiratory disease keywords and verified by chest HRCT. All eligible cases were stratified into CTD-ILD and CTD-CPFE groups based on emphysema presentation on re-assessed HRCT images.
Methods
Admission data, including demographics, comorbidities, inflammatory biomarkers, autoimmune antibodies, HRCT findings, pulmonary function test results and in-hospital treatment information, were collected for subsequent grouped analysis.
Results
445 CTD-ILD patients were included, and 48 (10.8%) were CPFE. Patients with CPFE were predominantly male (68.8%), had a higher prevalence of a smoking history (68.8% vs 31.2%, p < 0.001), a lower body mass index (BMI) (20.4 vs 22.2 kg/m 2 , P = 0.004), and a higher prevalence of prior tuberculosis (TB) (14.6% vs 4.3%, p = 0.009). Multivariable regression analysis showed that sex, BMI, smoking status, and history of TB were independently associated with CPFE. Male sex was associated with a markedly increased likelihood of CPFE ( p = 0.003). TB was associated with increased likelihood, whereas higher BMI was associated with reduced likelihood (odds ratio: 33 and 0.57, respectively).
Conclusion
CTD-CPFE may represent a distinct subgroup within CPFE, with several characteristic features, including a relatively lower prevalence of smoking history. A low BMI and a history of TB were associated with the presence of CPFE, highlighting the potential importance of nutritional and immune status in patients with CTD-ILD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, Hunan, China.
- Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, China.
- Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
ORCID-Profile: Shuwan Huang, Aiyuan Zhou, Wei Cheng, Qing Song, Yanan Wang, Haiyuan Tang, Ruoxi He, Pinhua Pan
Förderung
- Key R & D Program of Hunan Province
- the Natural Science Foundation of Hunan Province, China
- The National Key Clinical Specialist Construction Program of China
- The Youth Science Foundation of Xiangya Hospital
- the Scientific Research Project of Hunan Health Commission
- National Natural Science Foundation of China
- the Noncommunicable Chronic Diseases – National Science and Technology Major Project
- Project Program of National Clinical Research Center for Geriatric Disorders
Zitieren
APA
Huang, S., Zhou, A., Cheng, W., Song, Q., Zhang, X., Peng, W., Wang, Y., Tang, H., Lu, R., He, R., & Pan, P. (2026). The prevalence and unique clinical features of CPFE among patients with connective tissue disease–associated interstitial lung disease: a retrospective, real-world study. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261471313
Vancouver
Huang S, Zhou A, Cheng W, Song Q, Zhang X, Peng W, et al. The prevalence and unique clinical features of CPFE among patients with connective tissue disease–associated interstitial lung disease: a retrospective, real-world study. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261471313
BibTeX
@article{Huang2026,
author = {Huang, Shuwan and Zhou, Aiyuan and Cheng, Wei and Song, Qing and Zhang, Xiyan and Peng, Wenzhong and Wang, Yanan and Tang, Haiyuan and Lu, Rongli and He, Ruoxi and Pan, Pinhua},
title = {The prevalence and unique clinical features of CPFE among patients with connective tissue disease–associated interstitial lung disease: a retrospective, real-world study},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
volume = {20},
doi = {10.1177/17534666261471313}
}
EUVIMED